Skip to main content
OpenTrials

Clinical trial condition

Myeloproliferative Disorders

Explore clinical trials studying Myeloproliferative Disorders. Study availability and eligibility vary by location and protocol.

1,108 public trials 144 recruiting studies
Refine in advanced search Browse all conditions

Myeloproliferative Disorders trial results

Completed

Treatment-free Remission After Achieving Sustained MR4.5 on Nilotinib (ENESTop)

NCT01698905

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations
  • USC Kenneth Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Indiana Blood and Marrow Institute Beech Grove, Indiana, United States
  • St Agnes Hospital Baltimore, Maryland, United States
  • University of Texas Medical Branch Galveston, Texas, United States
View all 62 locations
View Trial Details
Completed

Study to Evaluate Safety, Pharmacokinetic and Pharmacodynamic Dose Escalation and Expansion Study of PXS-5505 in Patients With Primary, Post-polycythemia Vera or Post-essential Thrombocythemia Myelofibrosis

NCT04676529

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • Comprehensive Cancer Center (UAB CCC) Birmingham, Alabama, United States
  • Novant Health Cancer Institute Winston-Salem, North Carolina, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • Liverpool Hospital Liverpool, New South Wales, Australia
View all 23 locations
View Trial Details
Completed

Study of the JAK Inhibitor Ruxolitinib Administered Orally to Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera-Myelofibrosis (PPV-MF) or Post-Essential Thrombocythemia-Myelofibrosis (PET-MF)

NCT01317875

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • Winter Park, Florida, United States
  • Baltimore, Maryland, United States
  • Houston, Texas, United States
  • Vienna, Austria
View all 18 locations
View Trial Details

Related conditions